Swiss Chems YK 11 60 capsules

SWISS CHEMS MYOSTIN YK 11

£62.99
Skip to product information
Swiss Chems YK 11 60 capsules

SWISS CHEMS

SWISS CHEMS MYOSTIN YK 11

£62.99
Out of stock

Buy YK 11

60 Capsules | 5mg per Capsule | US SARMs

What Is YK11?

YK11, sometimes referred to as YK-11 SARM, is a synthetic androgen receptor modulator designed to interact selectively with androgen receptors. It was first developed to study the pathways involved in muscle and bone development.

In laboratory settings, YK-11 acts as a gene-specific agonist of the androgen receptor (AR) and influences multiple anabolic pathways. Studies on cell lines such as MDA-MB-453 and C2C12 myoblasts have shown that YK-11 can stimulate myogenic factors like MyoD and Myf5—key regulators of muscle cell differentiation.

Unlike injectable androgens, YK-11 is orally bioavailable, which allows researchers to evaluate its effects through oral administration in controlled environments.

YK 11 Benefits from Clinical Research

1. Muscle Growth and Follistatin Expression

One of YK-11’s defining features is its connection to follistatin, a naturally occurring protein that regulates muscle growth by inhibiting myostatin and related catabolic proteins (Activin A, Activin B).

Research suggests that YK-11 may stimulate follistatin expression both locally and systemically, which in turn can:

  • Promote muscle cell differentiation
  • Support amino acid and glucose uptake in skeletal muscle
  • Reduce myostatin-related muscle breakdown

This mechanism distinguishes YK-11 from traditional anabolic agents and provides a promising avenue for continued study into muscle preservation and recovery.

2. Bone Cell Research and Growth Potential

In vitro testing on MC3T3-E1 osteoblast cells showed that YK-11, alone or in combination with DHT, can accelerate cell proliferation and mineralization. The treatment also increased the expression of bone differentiation markers such as osteocalcin and osteoprotegerin.

These effects appear to be mediated through the androgen receptor (AR) and Akt phosphorylation pathway, which are important in bone tissue regulation and recovery.

3. Muscle Wasting and Cytokine Response

Animal studies examining sepsis-induced muscle loss have reported that YK-11 treatment correlated with:

  • Improved muscle tissue protection
  • Reduced cytokine-related inflammation
  • Lower mortality rates in experimental models

These outcomes were attributed to myostatin suppression and increased follistatin gene expression, making YK-11 a continuing focus in the field of muscle-wasting research.

Potential YK11 Side Effects

Published data on YK-11 side effects remains limited. However, anecdotal reports and structural similarities to other androgenic compounds suggest the need for caution in laboratory environments. Possible observations include:

  • Temporary joint discomfort
  • Skin and hair changes
  • Fluctuations in lipid and hormone markers

Because YK-11 acts on the androgen receptor, similar considerations apply as with other AR-modulating compounds. Researchers should handle this material under appropriate conditions and within approved safety protocols.

BROWSE YK-11 COLLECTION
SHIPPING & DELIVERY

At SMART SARMS, we aim to dispatch all UK orders placed before 2pm on the same working day. Orders placed after this time will generally be dispatched the next working day.

All UK orders are shipped using Royal Mail Tracked services, with tracking information provided once your order has been dispatched.

UK Shipping

  • Royal Mail Tracked 48 (£3.49) – Estimated 2–3 working day delivery.
  • Royal Mail Tracked 24 (£4.49) – Estimated 1 working day delivery.
  • FREE UK SHIPPING OVER £50 – Complimentary shipping on qualifying orders.

European Shipping

  • Royal Mail International Tracked (£8.00) – Tracked international delivery.
  • FREE EUROPEAN SHIPPING OVER £200 – Complimentary shipping on qualifying orders.

Important Shipping Information

Delivery times are estimates and may vary depending on destination, postal delays and circumstances outside our control. Dispatch times apply to working days only, excluding weekends and UK bank holidays.

For further information, please refer to our full Shipping & Delivery Policy.

FAQs

Is YK-11 prohibited in professional sport?

Yes. YK-11 falls under the World Anti-Doping Agency's prohibited category for other anabolic agents and is prohibited at all times, both in and out of competition.

What is YK-11 studied for?

Research has primarily examined androgen receptor activity, follistatin expression and myogenic differentiation. Studies have also investigated its effects on bone-cell activity.

What is the half-life of YK-11?

YK-11 has no officially established human half-life. Preclinical research in mice reported an estimated elimination half-life of approximately 1.75 hours following oral administration. However, this figure comes from animal research and should not be interpreted as an established human pharmacokinetic value. 

Does YK-11 lower testosterone?

YK-11 may suppress the body's natural testosterone production because it acts as a partial androgen receptor agonist. However, this effect has not been directly established in human studies, and its impact on testosterone and other hormone levels remains unknown.

For more information about commonly researched compounds like MK-677, check out our SARMs FAQ blog post

DISCLAIMER

This material is sold for use in laboratory research only. Terms of sale apply. Not for human consumption, nor for medical, veterinary or household use.

Plain Packaging

All orders are shipped in plain brown or white packaging, with no external branding or mention of SARMs, research compounds or product contents. 

Same-Day Dispatch

Orders placed before 2pm on working days are dispatched the same day, ensuring your order is on its way as quickly as possible.

COA On Request

Certificates of Analysis (COAs) are available upon request for additional product documentation and transparency.

YK-11 Scientific References

Selective Androgen Receptor Modulator, YK11, Regulates Myogenic Differentiation of C2C12 Myoblasts by Follistatin Expression

Summary: Researchers investigated how YK-11 influences muscle-cell differentiation using C2C12 mouse muscle cells. Results demonstrated increased expression of key myogenic regulatory factors, including MyoD, Myf5 and myogenin. YK-11 also increased follistatin expression, which appeared to play an important role in the observed muscle-cell differentiation.

Source: Kanno et al. (2013).

Selective Androgen Receptor Modulator, YK11, Up-Regulates Osteoblastic Proliferation and Differentiation in MC3T3-E1 Cells

Summary: Researchers examined the effects of YK-11 on osteoblast proliferation and differentiation using mouse bone-forming cells. Results demonstrated increased cell proliferation and mineralisation, alongside elevated expression of osteoblast markers, including osteoprotegerin and osteocalcin. The findings suggested that androgen receptor signalling was involved in these effects.

Source: Yatsu et al. (2018).

Studies on the In Vivo Metabolism of the SARM YK11: Identification and Characterization of Metabolites Potentially Useful for Doping Controls

Summary: Researchers investigated how YK-11 is metabolised and identified compounds produced during its breakdown. Using specialised mass spectrometry techniques, the study identified 14 urinary metabolites. Some conjugated metabolites remained detectable for more than 48 hours, providing useful information for analytical detection.

Source: Piper et al. (2018).

Equine Metabolism of the Selective Androgen Receptor Modulator YK-11 in Urine and Plasma Following Oral Administration

Summary: Researchers investigated YK-11 metabolism in Thoroughbred horses following administration. Results identified seven phase I metabolites in plasma and 11 in urine. The study also identified several breakdown products that remained detectable for longer than the original compound, contributing to research into YK-11 metabolism and analytical detection.

Source: Harding et al. (2023).

YK11 Promotes Osteogenic Differentiation of BMSCs and Repair of Bone Defects

Summary: Researchers investigated the effects of YK-11 on bone marrow-derived mesenchymal stem cells and bone repair. Results demonstrated increased osteogenic differentiation in laboratory experiments. In a rat model, YK-11 treatment also promoted the repair of cranial bone defects, with findings suggesting involvement of androgen receptor activation and the BMP2/Smad signalling pathway.

Source: Wang et al. (2025).

Researchers Also Ordered

Often Ordered Together